Hosted on MSN56m
Truist Securities Downgrades Merck (MRK)
Fintel reports that on January 8, 2025, Truist Securities downgraded their outlook for Merck (NYSE:MRK) from Buy to Hold.
Global Pain Treatment Market to Reach $144.2 Billion by 2029
According to the latest study from BCC Research, the demand for Conventional and Alternative Pain Treatment Markets is ...